Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer.
Artificial intelligence and allied subsets in early detection and preclusion of gynecological cancers.
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Intestinal microbial-derived sphingolipids are inversely associated with childhood food allergy.
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571. Oncogene. 2000 Jul 20; 19(31):3521-8.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Benzamides
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Cell Cycle
Dimethyl Sulfoxide
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Enzyme Inhibitors
Fusion Proteins, bcr-abl
Growth Inhibitors
Hematopoietic Stem Cells
Humans
Imatinib Mesylate
Lung Neoplasms
Megakaryocytes
Mice
Microscopy, Video
Neoplasm Proteins
Phosphorylation
Piperazines
Protein Processing, Post-Translational
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins c-kit
Pyrimidines
Reactive Oxygen Species
Tumor Cells, Cultured
authors with profiles
Ravi Salgia